The hemodynamic courses of 56 patients with congestive cardiomyopathy (CCM) were investigated. Fourteen patients died within 24 months after diagnosis. The hemodynamic courses of the remaining 42 patients were investigated in subsequent examinations by determination of left ventricular ejection fraction (LVEF), mean pulmonary arterial pressure at maximal workload, and peak systolic pressure/end-systolic volume index. During the study interval of 32.2 + 20.0 months the conditions of 20 patients (48%) deteriorated, according to their hemodynamic status, and at least five of these died of terminal heart failure. Surprisingly, the conditions of 22 patients (52%) improved or stabilized. One of these died of leukemia. Seven patients in the latter group with initial LVEFs of 0.30 or less experienced an average increase from 0.22 to 0.51. Retrospectively consideration of age, alcohol intake, exercise capacity, and hemodynamic status were not helpful in predicting the course of the disease. In 38 patients endomyocardial biopsy samples could be obtained at the time of diagnosis. Reduced myofibril volume fraction (<60%) had prognostic significance for both hemodynamic deterioration and death (sensitivity 23/24 = 96%), while 14 of 15 patients whose conditions improved or stabilized had a myofibril volume fraction of 60% or more (specificity 14/15 or 93%, p < .002). A relationship between hemodynamic status and the myofibril volume fraction could not be found. Individual patients with CCM differ significantly with respect to course of the disease. A distinct separation of the patients by means of morphologic criteria is possible. This makes it more likely that the pathogenesis of the disease is not unique.
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Circulation 71, No. 6, 1095-1104, 1985. CONGESTIVE CARDIOMYOPATHY (CCM) is the heart muscle disease that carries the poorest prognosis; the average yearly mortality rate for CCMI is about 10%." 2 The course of CCM has been described by several authors. '-8 Most previous studies have presented only cumulative survival rates, ' 1 so that the direct cause of death in patients with CCM remains unknown. Kuhn et al. ' analyzed the cause of death from CCM and stated that about 64% of these patients died from increasing cardiac congestion, 25% died because of sudden heart failure (arrhythmia is suspected), 12% died from thromboembolism, and 8% died of an unknown cause.
The risk of thromboembolism has been lessened by anticoagulant therapy' and the risk of sudden death due to arrhythmia might perhaps be decreased by electrophysiologic testing and new antiarrhythmic drugs, 9-b ut the problem of progressive pump failure remains. So far the long-term benefits of the pharmacologic treatment of progressive congestive heart failure in patients with CCM as measured by survival rates are disappointing."1'12 A research group in Sweden claims that long-term /-blockade offers some beneficial effects,1'1 14 but the mechanisms of these effects are not understood.
At the present time, heart transplantation seems to be the therapeutic approach with the best survival rate for patients with severely impaired pump function. '5 A hemodynamic longitudinal study of patients with CCM has not yet been published. Studies to date have assessed hemodynamic status by means of echocardiography, phonocardiography, scintigraphy, and standard chest x-ray in patients at rest." 2. However, the cardiothoracic ratio and other indirect criteria of myocardial performance might not correctly grade the severity of left ventricular dysfunction in a significant number of patients.'$' It is the purpose of this study to investigate the hemodynamic course of CCM reliably by use of semiinvasive methods in patients at rest and during exercise. We found that individual patients with CCM differ significantly with respect to hemodynamic course. This enabled us to investigate prognostic features.
Methods
Study protocol. The following diagnostic procedures were performed on entry of patients into the study: Left heart catheterization was performed in all patients and 38 patients underwent cardiac biopsy. Swan-Ganz thermodilution catheterization and simultaneous gated blood pool (GBP) scanning was also performed in 23 patients at rest and during exercise.
Reexaminations included Swan-Ganz catheterization/GBP scanning in all patients while at rest and during exercise. Also obtained in each patient at entry and on reexamination were a clinical workup, standard laboratory tests, a chest x-ray, an echocardiogram, and an electrocardiogram.
Techniques Left heart catheterization. Left heart catheterization was performed according to the Sones technique. Biplane cine ventriculograms and coronary angiograms were obtained according to standard techniques. The end-systolic and end-diastolic volume indexes (ESVI; EDVI) and the left ventricular ejection fraction (LVEF) during a normal cardiac cycle were evaluated according to the biplane area-length method of Dodge et al.`9 Peak systolic pressure (PSP) and end-systolic pressure of the left ventricle were recorded through the fluid-filled lumen of the catheter. The ratio of PSP/ESVI was determined and used as an index of manifest left ventricular contractility. x Swan-Ganz catheterization. Swan-Ganz catheterization was performed through a right cubital vein with a No. 7F-Swan-Ganz thermodilution catheter. The mean of three consecutive measurements of cardiac output was considered to be representative. Mean pulmonary arterial pressure (PAP) and mean pulmonary wedge pressure (PWP) were measured through the fluid-filled catheter. A cuff sphygmometer was used at the left brachial artery to determine PSP at the point where two consecutive first Korotkov sounds appeared. Gated blood pool (GBP) scanning. The equilibrium GBP scanning technique, without background correction, of Luig et al. 23 was used. Results obtained with this technique demonstrat ed a very good correlation to our biplane cineangiographic results (r = .97), with the regression line LVEFGBP 0.92 LVEFAngIo + 0.07. Thus, the error in the determination of LVEFGBP was in the range of 0.008 to 0.042 (LVEFAnO 0.20 to 0.60). The applied GBP scanning technique had a time resolution of 1 msec and was performed in list mode. By evaluating the scintigraphic data forward and backward in time relative to each central R wave electrocardiographic signal, the whole cardiac cycle could be described. By a two-parameter RR interval selection, patients with arrhythmias could be evaluated reliably. Human red blood cells labeled in vitro with 991'Tc (10 mCi) were used as the imaging agent. A convergent collimeter was used in the left lateral position (40 to 50 degrees) with additional cranial angulation (10 to 20 degrees) to the sagittal axis.
End-systolic volume (ESV) was determined with the formula area were used in three randomly chosen sections. Test points superimposed on interstitial structured tissue were related to all other points and this relationship was taken as the volume fraction of interstitial structured tissue. The volume fraction of the mvofibrils was evaluated by means of the same technique with oil immersion and phase contrast at a magnification of 1000x (figure 1). Light-microscopic values for myofibril volume fraction have been shown by Mall et al.'5 to correlate closely with electron microscopic val ues. Since light microscopy allows evaluation of a larger area of the biopsied tissue, this method was preferred to electron microscopy. According to Mall et al."5 the sampling variability in light microscopy is small, especially in the determination of the myofibril volume fraction and fiber diameter. Unfortunately the results of morphometric analysis in tissue obtained at biopsy cannot be compared with results in tissue obtained at autopsy, since autolysis of the latter effects the morphometric results. Mitochondrial and nucleus swelling reduces the relative tissue volume fraction of the myofibrils.
Fiber diameters of the myocardial cells were measured from 50 to 100 cross or oblique sections at a magnification of 420 x (oblique sections = short diameter of the section profile; cross sections = diameter of the cell at the level of the nucleus). All measurements were made without knowledge of the clinical data. To be included in the study group patients had to satisfy two or more of the following hemodynamic criteria at the time of the entry examination: resting LVEF less than 0.55, EDVI of greater than 100 ml.m-2 and/or ESVI greater than 40 mlM and PAP at exercise end points (PAPr,,9 greater than 35 of the heart muscle were not considered to have CCM and therefore were excluded from our study. The reinvestigation procedure was approved by the hospital ethical committee. Written informed consent of all patients was obtained for all left heart catheterization and biopsy procedures.
The study group consisted of 45 men (80%) and 1 1 women (20%). The mean age was 47.1 ± 9.7 (range 16 to 65) years. Severity of heart failure was classified according to the NYHA definition. Fourteen patients died within the first 24 months after diagnosis. The remaining 42 could be reexamined; six of these died after the reexamination. Classification oj'patients. Patients were considered to have deteriorating CCM if in the time between the two examinations changes in two of three of the following parameters of cardiac performance exceeded the level of significance: LVEF (decrease > 0.05 PAP1 X (increase > 3 mm Hg). and PSP/ESVI (decrease > 0.30 mm Hgml-iM).
Alcohol intake was graded on a scale of 0 to 3 (0 -no alcohol intake; + = alcohol on very rare occasions; + + <50 g alcohol per day; + + + = -50 g alcohol per day).
Therapy. The patients were tieated, according to the degree of heart failure, with digitalis, diuretics, and vasodilators. The antiarrhythmics given were mexiletine, propafenone, and amiodarone. Dicumarol was given to 24 patients as an oral anticoagulant. No cardiac medications other than antiarrhythmics were given less than 16 hr before examinations.
Statistical analysis. Differences in hemodynamic courses or among groups were tested with the Wilcoxon test, since normal distribution could not be presumed because of the nonlinearity of the parameters. Based on the null hypothesis. which states that there is no difference between the groups or results, twotailed tests were used. Probability values >.05 were considered to indicate nonsignificant differences. If more than two groups were compared univariate analysis of variance was used. In the case of discrete variates fourfold tables were used in combination with the exact Fisher or chi-square test. In table 4 Student's t test was used, since norm-al distribution could be presumed. Correlation coefficients were obtained with a standard formula.
Results
Hemodynamic course and survival. The hemodynamic courses of patients with CCM were determined in this study by means of the parameters of LVEF, PAPma, and PSP/ESVI. During the follow-up period of 32.2 + 20.0 months from the entry examination until the last reexamination three groups of patients emerged (figure 2). (1) Fourteen patients died before reexamination or within 2 years after the initial diagnosis (group 1). (2) Hg ml-m2 (table 1) . The individual changes and the mean parameter values in both groups are shown in figure 4 . The mean hemodynamic changes in each of the 42 patients were nonsignificant. Twenty-two patients in the study group were reexamined several times. In figure 5 the LVEFs of these patients in relation to time are shown. In most of the cases there was either a monotonic increase or decrease in the LVEF over time. Significant fluctuations in the LVEF, which would indicate a greater variability in the individual patient's contractility, were rare (three , *, *,, * , , *,,, _. . 1- §---. 1 A ' . A Ainstances). In figure 3 the curve of the cumulative survival rate is shown. The average yearly mortality rate amounted to 9%. Forty-two patients could be reexamined. In group 3 LVEF increased, on the average, from 0.386 to 0.551, PAPMdAX decreased from 38.6 to 28.9 mm Hg, and PSP/ESVI increased from 1 .94 to 2.88 mm Hg ml-l m'. In group 2, LVEF decreased from 0.392 to 0.282, PAP increased from 39.2 to 53.2 mm Hg, and PSP/ESVI decreased from 2.41 to 1.38 mm x-ray and echocardiography.
In table 3 the hemodynamic characteristics of the patients are compared. Again no significant difference at the time of diagnosis could be detected, a finding that might be of prognostic significance.
In figure 6 data on the hemodynamic courses of 18 patients with LVEFs of 0.30 or less at the time of diagnosis are illustrated. Eleven of these deteriorated or died, while seven improved. Although 34 of the 56 patients studied died or their conditions deteriorated, of all only 1 1 of these had LVEFs of 0.30 or less at the time of diagnosis. LVEF of 0.30 or less used as an indication of deterioration had a sensitivity of only 11/34 (29%). The specificity was 15/22 (68%), and therefore the predictivevaluewasll/18(61%;X2 = 1.64;p>.1).Therefore, the deduction of a prognosis from the degree of left ventricular dysfunction at the time of diagnosis is neither sensitive nor specific.
Results of biopsies. In 38 patients endomyocardial biopsy samples could be obtained at the entrance examination. None of the samples showed any evidence of myocarditis or classified myocardial diseases. In 33 samples evaluation of the volume fraction of myofibrils could be performed by means of histologic morphometry and 18 of these showed myofibril volume fractions of less than 60%, while 15 showed myofibril fractions of 60% or greater.
Data on the hemodynamic courses of the surviving patients with myofibril volume fractions of 60% or greater (n = 25) and with myofibril volume fractions of less than 60% are illustrated in figure 7 . Compared with LVEF and PSP/ESVI at the time of diagnosis, there was a significant increase in these parameters in the patients with volume fractions of 60% or greater, and a decrease in these parameters in patients in the less than 60% group within 31.2 + 16.0 months. The change in PAP,,, was not significant in either group.
However, nine of 10 patients whose conditions deteriorated had myofibril volume fractions of less than 60% (sensitivity 9/10 or 90%). Fourteen of 15 patients whose conditions improved or stabilized had myofibril volume fractions of 60% or greater (specificity 14/15 or 93%; p < .002). The myofibril volume fractions of all patients who died before the first reexamination were less than 60% (n = 8). Thus, a myofibril volume fraction of less than 60% appears to be an appropriate prognostic index of hemodynamic deterioration or death. The probability that a patient with CCM and a myofibril volume fraction in this range will deteriorate or die is 93% (prevalence = 0.6).
Myocyte fiber diameter could not be related to the course of the disease. The volume fraction of the interstitial structured tissue was elevated in the case of hemodynamic deterioration, but this difference barely reached the level of significance (table 4) .
Although patients in groups 1, 2, and 3 differed with respect to the amount of myofibrils present, no major distinctions could be made in their clinical or hemodynamic status at the time of the initial diagnosis. When the correlations between the myofibril volume fraction and LVEF or PSP/ESVI were plotted (figure 8), the correlation was poor (r = .25, r = .29). 
Discussion
The course of CCM. In this study the c( of 56 patients with CCM was investigi tricular function was determined at subs nations at rest and during exercise by me phase (LVEF) and pressure indexes ( PSP/ESVI, the last of which was interi and is said to be a sensitive parameter o lar contractility and to be especially s LVEF range above 0.50.2-22 These thi allowed us to reliably evaluate and defir namic courses of our patients.
It was the aim of this study to observ namic courses of patients with CCM ov time period. Consequently patients w ventricular dysfunction were also includ amined several times and it appeared that improvements in left ventricular function were sustained (figure 5). In patients with CCM the prognostic significance of the following variables can be ruled out: age, sex. left bundle branch block, alcohol consumption, heart rate, systolic blood pressure, left ventricular end-diastolic volume, LVEF at rest. PAP, and the index of left ventricular contractility PSP/ESVI (tables 2 and 3).
The prognostic significance of left ventricular hypertrophy, which reduces wall stress,7 ' and the significance of levels of plasma catecholamines' were not investigated.
Myocardial biopsy. In our study we examined 38 biopsy samples. In 33 specimens the volume fraction of the myofibrils could be determined and was found to be significantly reduced in groups 1 and 2 (table 4). The hemodynamic courses of the patients with myofibril volume fractions of less than 60% vs those in patients with fractions of 60% or greater are illustrated in figure 7 . A clear separation can be seen. A myofibril volume fraction of less than 60%c served as an appropriate prognostic index for hemodynamic deterioration or death in our study group (p < .002. sensitivity 90%, specificity 93%c ).
Other histomorphometric findings in the biopsy samples, such as myocyte fiber diameter and the volume fraction of interstitial structured tissue, could not be related to the course of the disease. Mall et al.>5 found that sampling variability with endomyocardial biopsy was low for determination of fiber diameter and volume fraction of myofibrils when compared with variability in determination of volume fraction of interstitial structured tissue. This leads us to the conclusion that small endomyocardial biopsy samples are highly representative with respect to fiber diameter and myofibril volume fraction and are less representative with respect to interstitial fibrosis. Unfortunately, validation of the histomorphometric biopsy findings cannot be performed ad exitum at autopsy, since autolysis of myocardium will greatly affect the results.
We used light microscopy to determine the volume fraction of myofibrils to reduce the sampling error, which is naturally higher with electron microscopy. A strong correlation between light and electron microscopic findings was demonstrated by Mall et al.>
The determination of the myofibril volume fraction by light microscopy is only an integrative method, because it cannot be used to distinguish between mitochondrial swelling, mitochondrial accumulation, and degeneration of myofibrils. All of these events can reduce the relative volume fraction of the myofibrils. The histologic picture of CCM is nonspecific and nonpathognomonic.0>32 The results of various studies show that the three diagnostic groups -"ordinary" hypertrophy, hypertrophic cardiomyopathy, and CCM overlap.3032 The question remains as to whether such nonspecific tissue disorders can be related to hemodynamic performance and the hemodynamic courses of patients. Kuhn et al.6 used a morphologic score and demonstrated a higher mortality rate in patients with extended ultrastructural myocardial lesions. Mall et al. 25 and Kunkel et al. 32 34 confirmed the latter results, and they were also able to correlate LVEF with the amount of the myofibril volume fraction. In another study it was found that in patients with aortic stenosis the myofibril volume fraction (contractile mass) correlated with LVEF. 33 In contrast, Baandrup et al. 30 35 could not confirm the relationship between morphologic changes and the functional status of patients or their prognosis. However, these authors did not assess the hemodynamic course by semi-invasive means.
In this study a highly significant relationship between myofibril volume fraction and hemodynamic course was found. Other histologic parameters could not be related to hemodynamic course.
In agreement with the results of Baandrup et al. , 30 35 we did not find any correlation between left ventricular function and the myofibril volume fraction ( figure 8 ). Therefore, the possibility that reduced myofibril volume fraction is only a nonspecific phenomena related to reduced left ventricular function could be excluded.
Our results demonstrate that there are two groups of patients with CCM that differ with respect to their hemodynamic courses and morphologic features. This makes it more likely that the pathogenesis of the disease is not unique, and if it is not, the entity CCM can be divided into a progressive and nonprogressive form. Our present findings suggest that temporally depressed left ventricular function of unknown cause and without morphometric expression can exist. Use of experimental therapies suggested for CCM, e.g., /3-blocker therapy,"' 12 36 should be restricted to the homogeneous group of patients with reduced myofibrils because spontaneous improvement in the others might interfere with therapeutic effects.
In the future prospective evaluation of the courses of individual patients should be possible by determination of myofibril volume fraction. The prognosis should not be determined from the contractile status.
Heart transplants should not be performed in patients with myofibril volume fractions of 60% or more, since the prognosis for these patients is good.
